TY  - JOUR
AU  - Mihajlović, Marija
AU  - Ninić, Ana
AU  - Sopić, Miron
AU  - Miljković, Milica
AU  - Stefanović, Aleksandra
AU  - Vekić, Jelena
AU  - Spasojević-Kalimanovska, Vesna
AU  - Zeljković, Dejan
AU  - Trifunović, Bratislav
AU  - Stjepanović, Željka
AU  - Zeljković, Aleksandra
PY  - 2019
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3458
AB  - Background: Elevated concentrations of resistin have been reported in colorectal cancer (CRC), but its interactions with adenylate cyclase-associated protein 1 (CAP-1) are largely unexplored. We investigated resistin plasma concentration, peripheral blood mononuclear cells (PBMCs) resistin messenger ribonucleic acid (mRNA), and CAP-1 mRNA levels in CRC patients, as well as the impact of resistin gene polymorphism rs1862513 on the examined markers. We also explored associations of resistin with high-density lipoprotein cholesterol (HDL-C) and predictive potential of our parameters for CRC. Methods: Eighty-six patients with CRC and 75 healthy adults were included. Commercial ELISA kit was used for obtaining resistin’s concentrations, while polymerase chain reaction (PCR) method was applied for evaluation of resistin and CAP-1 mRNA levels and rs1862513 polymorphism. Results: Plasma resistin and CAP-1 mRNA levels were higher in CRC patients (p < 0.001 and p < 0.05, respectively), while resistin mRNA levels were lower (p < 0.001). Negative association existed among plasma resistin and HDL-C concentrations (ρ = − 0.280; p < 0.05). A model including age, body-mass index, HDL-C, low-density lipoprotein cholesterol (LDL-C), and plasma resistin concentrations as independent predictors of CRC showed very good diagnostic accuracy (AUC = 0.898). We found no associations of rs1862513 with the examined markers. Conclusions: Our study demonstrated increased plasma resistin and CAP-1 mRNA levels, implying their possible interaction in CRC. The association among plasma resistin and HDL-C might indicate that HDL-C is involved in alterations of resistin’s secretion process. As a hallmark of personalized medicine, multi-marker approach in determination of resistin-related parameters might be useful for prediction and prevention of CRC development.
PB  - Springer
T2  - EPMA Journal
T1  - Association among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicine
VL  - 10
SP  - 307
EP  - 316
DO  - 10.1007/s13167-019-00178-x
ER  - 

@article{
author = "Mihajlović, Marija and Ninić, Ana and Sopić, Miron and Miljković, Milica and Stefanović, Aleksandra and Vekić, Jelena and Spasojević-Kalimanovska, Vesna and Zeljković, Dejan and Trifunović, Bratislav and Stjepanović, Željka and Zeljković, Aleksandra",
year = "2019",
abstract = "Background: Elevated concentrations of resistin have been reported in colorectal cancer (CRC), but its interactions with adenylate cyclase-associated protein 1 (CAP-1) are largely unexplored. We investigated resistin plasma concentration, peripheral blood mononuclear cells (PBMCs) resistin messenger ribonucleic acid (mRNA), and CAP-1 mRNA levels in CRC patients, as well as the impact of resistin gene polymorphism rs1862513 on the examined markers. We also explored associations of resistin with high-density lipoprotein cholesterol (HDL-C) and predictive potential of our parameters for CRC. Methods: Eighty-six patients with CRC and 75 healthy adults were included. Commercial ELISA kit was used for obtaining resistin’s concentrations, while polymerase chain reaction (PCR) method was applied for evaluation of resistin and CAP-1 mRNA levels and rs1862513 polymorphism. Results: Plasma resistin and CAP-1 mRNA levels were higher in CRC patients (p < 0.001 and p < 0.05, respectively), while resistin mRNA levels were lower (p < 0.001). Negative association existed among plasma resistin and HDL-C concentrations (ρ = − 0.280; p < 0.05). A model including age, body-mass index, HDL-C, low-density lipoprotein cholesterol (LDL-C), and plasma resistin concentrations as independent predictors of CRC showed very good diagnostic accuracy (AUC = 0.898). We found no associations of rs1862513 with the examined markers. Conclusions: Our study demonstrated increased plasma resistin and CAP-1 mRNA levels, implying their possible interaction in CRC. The association among plasma resistin and HDL-C might indicate that HDL-C is involved in alterations of resistin’s secretion process. As a hallmark of personalized medicine, multi-marker approach in determination of resistin-related parameters might be useful for prediction and prevention of CRC development.",
publisher = "Springer",
journal = "EPMA Journal",
title = "Association among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicine",
volume = "10",
pages = "307-316",
doi = "10.1007/s13167-019-00178-x"
}

Mihajlović, M., Ninić, A., Sopić, M., Miljković, M., Stefanović, A., Vekić, J., Spasojević-Kalimanovska, V., Zeljković, D., Trifunović, B., Stjepanović, Ž.,& Zeljković, A.. (2019). Association among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicine. in EPMA Journal
Springer., 10, 307-316.
https://doi.org/10.1007/s13167-019-00178-x

Mihajlović M, Ninić A, Sopić M, Miljković M, Stefanović A, Vekić J, Spasojević-Kalimanovska V, Zeljković D, Trifunović B, Stjepanović Ž, Zeljković A. Association among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicine. in EPMA Journal. 2019;10:307-316.
doi:10.1007/s13167-019-00178-x .

Mihajlović, Marija, Ninić, Ana, Sopić, Miron, Miljković, Milica, Stefanović, Aleksandra, Vekić, Jelena, Spasojević-Kalimanovska, Vesna, Zeljković, Dejan, Trifunović, Bratislav, Stjepanović, Željka, Zeljković, Aleksandra, "Association among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicine" in EPMA Journal, 10 (2019):307-316,
https://doi.org/10.1007/s13167-019-00178-x . .

TY  - JOUR
AU  - Stevanović, Milica
AU  - Vekić, Jelena
AU  - Bogavac-Stanojević, Nataša
AU  - Janać, Jelena
AU  - Stjepanović, Željka
AU  - Zeljković, Dejan
AU  - Trifunović, Bratislav
AU  - Spasojević-Kalimanovska, Vesna
AU  - Zeljković, Aleksandra
PY  - 2018
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3048
AB  - Introduction: Dyslipidaemia contributes to the occurrence of colorectal cancer (CRC). We hypothesized that qualitative changes of lipoproteins are associated with the risk for CRC development. This study analyses low-density lipoprotein (LDL) and high-density lipoprotein (HDL) diameters, as well as distribution of LDL and HDL subclasses in patients with CRC, with an aim to determine whether advanced lipid testing might be useful in predicting the risk for the onset of this malignancy. Materials and methods: This case-control study included 84 patients with newly diagnosed CRC and 92 controls. Gradient gel electrophoresis was applied for separation of lipoprotein subclasses and for LDL and HDL diameters determination. Lipid parameters were measured using routine enzymatic methods. Results: Total cholesterol, HDL and LDL-cholesterol were significantly lower in CRC patients compared to controls (4.47 mmol/L vs. 5.63 mmol/L; 0.99 mmol/L vs. 1.27 mmol/L; 2.90 mmol/L vs. 3.66 mmol/L; P  lt  0.001, respectively). Patients had significantly smaller LDL (25.14 nm vs. 26.92 nm; P  lt  0.001) and HDL diameters (8.76 nm vs. 10.17 nm; P  lt  0.001) and greater proportion of small, dense LDL particles (54.0% vs. 52.9%; P = 0.044) than controls. Decreased LDL and HDL diameters were independent predictors of CRC (OR = 0.5, P = 0.001 and OR = 0.5, P = 0.008, respectively), and alongside with age and HDL-cholesterol concentrations formed the optimal cost-effective model, providing adequate discriminative abilities for CRC (AUC = 0.89) and correct patients classification (81%). Conclusions: Patients with CRC have decreased LDL and HDL diameters and increased proportion of smaller particles. LDL and HDL diameters determination could be useful in assessing the risk for CRC development.
PB  - Croatian Soc Medical Biochemists, Zagreb
T2  - Biochemia Medica
T1  - Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development
VL  - 28
IS  - 3
DO  - 10.11613/BM.2018.030713
ER  - 

@article{
author = "Stevanović, Milica and Vekić, Jelena and Bogavac-Stanojević, Nataša and Janać, Jelena and Stjepanović, Željka and Zeljković, Dejan and Trifunović, Bratislav and Spasojević-Kalimanovska, Vesna and Zeljković, Aleksandra",
year = "2018",
abstract = "Introduction: Dyslipidaemia contributes to the occurrence of colorectal cancer (CRC). We hypothesized that qualitative changes of lipoproteins are associated with the risk for CRC development. This study analyses low-density lipoprotein (LDL) and high-density lipoprotein (HDL) diameters, as well as distribution of LDL and HDL subclasses in patients with CRC, with an aim to determine whether advanced lipid testing might be useful in predicting the risk for the onset of this malignancy. Materials and methods: This case-control study included 84 patients with newly diagnosed CRC and 92 controls. Gradient gel electrophoresis was applied for separation of lipoprotein subclasses and for LDL and HDL diameters determination. Lipid parameters were measured using routine enzymatic methods. Results: Total cholesterol, HDL and LDL-cholesterol were significantly lower in CRC patients compared to controls (4.47 mmol/L vs. 5.63 mmol/L; 0.99 mmol/L vs. 1.27 mmol/L; 2.90 mmol/L vs. 3.66 mmol/L; P  lt  0.001, respectively). Patients had significantly smaller LDL (25.14 nm vs. 26.92 nm; P  lt  0.001) and HDL diameters (8.76 nm vs. 10.17 nm; P  lt  0.001) and greater proportion of small, dense LDL particles (54.0% vs. 52.9%; P = 0.044) than controls. Decreased LDL and HDL diameters were independent predictors of CRC (OR = 0.5, P = 0.001 and OR = 0.5, P = 0.008, respectively), and alongside with age and HDL-cholesterol concentrations formed the optimal cost-effective model, providing adequate discriminative abilities for CRC (AUC = 0.89) and correct patients classification (81%). Conclusions: Patients with CRC have decreased LDL and HDL diameters and increased proportion of smaller particles. LDL and HDL diameters determination could be useful in assessing the risk for CRC development.",
publisher = "Croatian Soc Medical Biochemists, Zagreb",
journal = "Biochemia Medica",
title = "Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development",
volume = "28",
number = "3",
doi = "10.11613/BM.2018.030713"
}

Stevanović, M., Vekić, J., Bogavac-Stanojević, N., Janać, J., Stjepanović, Ž., Zeljković, D., Trifunović, B., Spasojević-Kalimanovska, V.,& Zeljković, A.. (2018). Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development. in Biochemia Medica
Croatian Soc Medical Biochemists, Zagreb., 28(3).
https://doi.org/10.11613/BM.2018.030713

Stevanović M, Vekić J, Bogavac-Stanojević N, Janać J, Stjepanović Ž, Zeljković D, Trifunović B, Spasojević-Kalimanovska V, Zeljković A. Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development. in Biochemia Medica. 2018;28(3).
doi:10.11613/BM.2018.030713 .

Stevanović, Milica, Vekić, Jelena, Bogavac-Stanojević, Nataša, Janać, Jelena, Stjepanović, Željka, Zeljković, Dejan, Trifunović, Bratislav, Spasojević-Kalimanovska, Vesna, Zeljković, Aleksandra, "Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development" in Biochemia Medica, 28, no. 3 (2018),
https://doi.org/10.11613/BM.2018.030713 . .